Efficacy of artemether-lumefantrine treatment in patients with acute uncomplicated falciparum malaria in Mayotte, a French collectivity of the Comoros archipelago

Parasite

Volumn 11, Issue 3, 2004, Pages 325-328

  Tall, A ^a   Raharimalala, L A ^a   Lepere, J F ^b   Receveur, M C ^c   Baur, F ^b   Rabarijaona, L P ^a   Randrianarivelojosia, M ^a   Macarry, A ^b   Roussin, C ^b   Roussin, J M ^b   Robert, V ^a,d   Ariey, F ^a  

^a INSTITUT PASTEUR DE MADAGASCAR   (Madagascar)

^b DASS ^*  (Mayotte)

^c CENTRE HOSPITALIER DE MAYOTTE   (France)

^d UR 77 Paludisme Afro Tropical   (Madagascar)

Author keywords

Artemether lumefantrine; Chemotherapy; Coartem ; France; Malaria; Mayotte; Plasmodium falciparum

Indexed keywords

ARTEMETHER PLUS BENFLUMETOL;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL TRIAL; COMOROS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; FRANCE; HUMAN; INDIAN OCEAN; MAJOR CLINICAL STUDY; MALARIA FALCIPARUM; MALE; MAYOTTE; PARASITEMIA; SIDE EFFECT; TREATMENT FAILURE;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; ANIMALS; ANTIMALARIALS; ARTEMISININS; CHILD; CHILD, PRESCHOOL; COMOROS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG RESISTANCE; ETHANOLAMINES; FEMALE; FLUORENES; HUMANS; MALARIA, FALCIPARUM; MALE; MIDDLE AGED; PARASITIC SENSITIVITY TESTS; PLASMODIUM FALCIPARUM; SESQUITERPENES; TREATMENT FAILURE; TREATMENT OUTCOME;

PLASMODIUM FALCIPARUM;

EID: 19944417234     PISSN: 1252607X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. ARIEY F., RANDRIANARIVELOJOSIA M., DUCHEMIN J.B., RAKOTONDRAMARINA D., OULEDI A., ROBERT V., JAMBOU R., JAHEVITRA M., ANDRIANANTENAINA H., RAHARIMALALA L. & MAUCLERE P. Mapping of a Plasmodium falciparum pfcrt K76T mutation: a useful strategy for controlling chloroquine resistance in Madagascar. The Journal of Infectious Diseases, 2002, 185, 710-712.
2. DURAND R., JAFARAI S., BOUCHAUD O., RALAIMAZAVA P., KEUNDJIAN A. & LE BRAS J. Plasmodium falciparum: pfcrt and dhfr mutations are associated with chloroquine and proguanil prophilaxis failures in travelers. The Journal of Infectious Diseases, 2001, 184, 1633-1634.
3. HATZ C., ABDULLA S., MULL R., SCHELLENBERG D., GATHMANN I., KIBATALA P., BECK H.P., TANNER M., ROYCE C. Efficacy and safety of CGP 56697 (artemether and benflumetol) compared with chloroquine to treat acute falciparum malaria in Tanzanian children aged 1-5 years. Tropical Medicine and International Health, 1998, 3, 498-504.
4. JULVEZ J. & GALTIER J. Etude in vivo de la chloroquinoré sistance du P. falciparum à Mayotte. Médecine Tropicale, 1989, 49, 63-65.
5. KROGSTAD D.J. Malaria as a re-emerging disease. Epidemiological review, 1996, 18, 77-89.
6. KSHIRSAGAR N.A., GOGTAY N.J., MOORTHY N.S., GARG M.R., DALVI S.S., CHOGLE A.R., SORABJEE J.S., MARATHE S.N., TILVE G.H., BHATT A.D., SANE S.P., MULL R. & GATHMANN I. A randomized, double-blind, parallel-group, comparative safety, and efficacy trial of oral co-artemether versus oral chloroquine in the treatment of acute uncomplicated Plasmodium falciparum malaria in adults in India American Journal of Tropical Medicine and Hygiene, 2000, 62, 402-408.
7. LÉONG POCK TSY J.M., ELISSA N., OULEDI A., ARIEY F., DUCHEMIN J.B. & ROBERT V. Caractérisation moléculaire des moustiques du complexe Anopheles gambiae à Mayotte et à Grande Comore. Parasite, 2003, 10, 273-276. Erratum Parasite, 2003, 10, 370.
8. LOOAREESUVAN S., WILAIRATANA P., CHOKEJINDACHAI W., CHALERMRUT K., WERNSDORFER W., GEMPERLI B., GATHMANN I. & ROYCE C. A randomised, double-blind, comparative trial of a new oral combination of artemether and benflumetol (CGP 56697) with and mefloquine in the treatment of acute plasmodium falciparum malaria in Thaïland. American Journal of Tropical Medicine and Hygiene, 1999, 60, 238-243.
9. PIPER R., LEBRAS J., WENTWORTH L., HUNT-COOKE A., HOUZE S., CHIODINI P. & MAKLER M. Immunocapture diagnostic assays for malaria using Plasmodium Lactate Deshydrogenase (pLDH) American Journal of Tropical Medicine and Hygiene, 1999, 60, 109-118.
10. ROUSSIN J.M., HUART V., LEPERE J.F., LE BRAS M.J., ROUSSIN C. & LE BRAS J. Dépistage rapide du paludisme et génotypes de chimiorésistance de P. falciparum à Mayotte en 2001. Presse Médicale, 2002, 31, 1312.
11. VAN AGTMAEL M., BOUCHAUD O., MALVY D., DELMONT J., DANIS M., BARETTE S., GRAS C., BERNARD J., TOUZE J.E., GATHMANN I. & MULL R. The comparative efficacy and tolerability of CGP 56697 (artemether+lumefantrine) versus halofantrine in the treatment of uncomplicated falciparum malaria in travellers returning from the Tropics to The Netherlands and France. International Journal of Antimicrobial Agents, 1999, 12, 159-169.
12. VAN VUGT M., BROCKMAN A., GEMPERLI B., LUXEMBURGER C., GATHMANN I., ROYCE C., SLIGHT T., LOOAREESUWAN S., WHITE N.J. & NOSTEN F. Randomised comparison of artemetherbenflumetol and artesunate-Mefloquine in treatment of multi-drug resistant falciparum malaria. Antimicrobial Agents & Chemotherapy, 1998, 42, 135-139.
13. VAN VUGT M., EZZET F., NOSTEN F., GATHMANN I., WILAIRATANA P., LOOAREESUWAN S. & WHITE N.J. No evidence of cardiotoxicity during treatment with artemether-lumefanrine. American Journal of Tropical Medicine and Hygiene, 1999, 61, 964-967.
14. WARRELL D.A., MOLYNEUX M.E. & BEALES P.F. Severe and complicated malaria. Transactions of the Royal Society of Tropical Medicine and Hygiene, 1990, 84, 1-65.
15. WHITE N.J. Antimalarial drug resistance : the pace quickens. Antimicrobial Agents Chemotherapy, 1992, 30, 571-585.
16. WHITE N.J., NOSTEN F., LOOAREESUWAN S., WATKINS W.M., MARSH K., SNOW R.W., KOKWARO G., OUMA J., HIEN T.T., MOLYNEUX M.E., TAYLOR T.E., NEWBOLD C.I., RUEBUSH T.K. 2ND, DANIS M., GREENWOOD B.M., ANDERSON R.M. & OLLIARO P. Averting a malaria disaster. The Lancet, 1999, 353, 1965-1967.
17. WHO. World Health Organisation Assessment oh therapeutic efficacy of antimalarial drugs for uncomplicated falciparum malaria in areas with intense transmission. Report no. WHO/MALA/96.1077. World Health Organisation, Geneva, Switzerland, 1996.